ESSIBS Stock Overview
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Essity AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr263.90 |
52 Week High | kr312.55 |
52 Week Low | kr232.95 |
Beta | 0.18 |
1 Month Change | 9.03% |
3 Month Change | n/a |
1 Year Change | -13.42% |
3 Year Change | -4.38% |
5 Year Change | -5.72% |
Change since IPO | 7.80% |
Recent News & Updates
Recent updates
Shareholder Returns
ESSIBS | GB Household Products | GB Market | |
---|---|---|---|
7D | 6.0% | 2.9% | 1.7% |
1Y | -13.4% | -18.0% | 1.4% |
Return vs Industry: ESSIBS exceeded the UK Household Products industry which returned -18.7% over the past year.
Return vs Market: ESSIBS underperformed the UK Market which returned 1.1% over the past year.
Price Volatility
ESSIBS volatility | |
---|---|
ESSIBS Average Weekly Movement | n/a |
Household Products Industry Average Movement | 5.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: ESSIBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ESSIBS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1849 | 36,000 | Magnus Groth | www.essity.com |
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through Health & Medical, Consumer Goods, and Professional Hygiene segments. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, wet wipes, wash gloves, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family caregivers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce.
Essity AB (publ) Fundamentals Summary
ESSIBS fundamental statistics | |
---|---|
Market cap | kr189.53b |
Earnings (TTM) | kr9.03b |
Revenue (TTM) | kr145.65b |
21.0x
P/E Ratio1.3x
P/S RatioIs ESSIBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ESSIBS income statement (TTM) | |
---|---|
Revenue | kr145.65b |
Cost of Revenue | kr99.88b |
Gross Profit | kr45.77b |
Other Expenses | kr36.74b |
Earnings | kr9.03b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 18, 2024
Earnings per share (EPS) | 12.86 |
Gross Margin | 31.42% |
Net Profit Margin | 6.20% |
Debt/Equity Ratio | 63.6% |
How did ESSIBS perform over the long term?
See historical performance and comparison